Scientists have discovered that combining two existing drugs can dramatically reduce liver fat linked to a common and often silent disease. The treatment not only improved liver health in animal ...

A small cluster of damaged immune cells can do outsized harm. That is the picture emerging from new research at UCLA, where ...

New genetic map of the human liver reveals why certain areas are more susceptible to fatty liver disease while others are ...

I stared at the MRI scan on my computer screen with a mixture of alarm and disbelief. The large pink swathes coating my ...

Despite its scale, steatotic liver disease remains largely absent from global and US noncommunicable disease strategies.

Nearly two billion people could have fatty liver disease by 2050, marking a silent global health crisis linked to rising ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects nearly one in three adults around the globe. It starts when fat builds up inside the liver’s cells. Over time, this buildup can ...

There is considerable evidence that microplastics and nanoplastics are present in the livers of humans, and wild animal ...

Discover a promising new treatment for MASLD. A recent study shows how a combination of two existing drugs, pemafibrate and ...

Through years of monitoring, a cancer diagnosis and two liver transplants, Rivera found a passion for liver health advocacy.

Sophie Byroade was scrolling on Facebook last summer when she stumbled on an unusual post: It was from a mother looking for a liver donor for her sick three-year-old son. “Nolan needs a liver hero,” ...

The forecasting model projects that without major intervention, 1.8 billion people will have MASLD by 2050, and a ...